A Phase II Study of Gleevec in Ph+ Chronic Phase Chronic Myelogenous Leukemia.
Phase of Trial: Phase II
Latest Information Update: 16 Jan 2013
At a glance
- Drugs Imatinib (Primary)
- Indications Chronic myeloid leukaemia
- Focus Adverse reactions; Biomarker; Therapeutic Use
- 31 Aug 2018 Biomarkers information updated
- 13 Oct 2007 Status changed from in progress to completed.
- 21 Aug 2007 Status change from suspended to in progress